Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NetcareSTU:NH7 81 3-Year EBITDA Growth Rate is 15.10% as of Mar. 2026, which is 47% above its 10-year median of 10.30. GuruFocus rates STU:NH7 with a GF Score™ of 81/100 and a GF Value™ of €0.10. The stock has 8 warning signs investors should review. Among 526 Healthcare Providers & Services companies, Netcare ranks better than 58.56% on this metric.
During the past 12 months, Netcare's average EBITDA Per Share Growth Rate was 13.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 15.10% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 13.90% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 4.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Netcare was 43.00% per year. The lowest was -26.10% per year. And the median was 10.30% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Netcare 3-Year EBITDA Growth Rate Related Terms
STU:NH7 vs HCA, THC, EHC: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Netcare's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Netcare 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Netcare's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Netcare's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 15.10% mean?
Netcare (STU:NH7) has a 3-Year EBITDA Growth Rate of 15.10% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Netcare and its competitors. This is 47% above median its historical median of 10.30. According to the industry distribution chart, Netcare ranks #218 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 41.4%.
Is Netcare's 3-Year EBITDA Growth Rate too high?
Netcare's current 3-Year EBITDA Growth Rate of 15.10% is 47% above median its 10-year median of 10.30. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.05. Netcare's value of 15.10% is 50.2% above this industry median. Based on the distribution chart, Netcare ranks #218 out of 526 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Netcare has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Netcare's 3-Year EBITDA Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Netcare ranks #218 out of 526 companies for 3-Year EBITDA Growth Rate. This puts Netcare in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.05. Netcare's value of 15.10% is 50.2% above this benchmark. While the company's 10-year median is 10.30 vs. the industry median of 10.05, Netcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Netcare's current 3-Year EBITDA Growth Rate of 15.10% is 50.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Netcare and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Netcare's current 3-Year EBITDA Growth Rate is 15.10%, which is 47% above median its own 10-year median of 10.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Netcare stock overvalued right now?
Netcare (STU:NH7) has a current 3-Year EBITDA Growth Rate of 15.10%. The stock's GF Value™ is €0.10, compared to a current price of €0.10 — trading right at its estimated fair value. The current 3-Year EBITDA Growth Rate is 15.10%, which is 47% above median its 10-year median of 10.30 and 50.2% above the Healthcare Providers & Services industry median of 10.05. Netcare's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Netcare (STU:NH7), the current 3-Year EBITDA Growth Rate is 15.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Netcare (STU:NH7) Overvalued in 2026?
Based on GuruFocus' analysis, Netcare stock appears to be undervalued.
The current stock price of €0.10 is trading 0% below its estimated GF Value™ of €0.10.
Key valuation signals for STU:NH7:
3-Year EBITDA Growth Rate: 15.10% (47% above median its 10-year median of 10.30)
GF Value™: €0.10 vs. price of €0.10 (0% below fair value)
Industry Position: 50.2% above the Healthcare Providers & Services median (#218 of 526)
No single metric tells the full story. See the STU:NH7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Netcare Ltd operates a network of hospitals in South Africa. Its network also includes emergency, cancer care, diagnostic support, primary care, and renal care services as well as occupational health and wellness services. The firm operates in two segments: Hospital and emergency services and Primary Care. The Hospital and emergency services segment contributes to majority of the firm's revenue. Netcare's services include Netcare appointmed TM, Netcare Cancer Care, Netcare Family Connect Line, Netcare Occupational Health and Netcare Pharmacy.
81GF Score
Get the complete analysis for STU:NH7
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:NH7 has been successfully added to your 
